Related to this topic: Equipment | Books | Your Experience | Other resources | Glossaries
Print options: Printer friendly version of this leaflet (html)     Other options:  AddThis Social Bookmark Button (what's this?)

PatientPlus articles are written for doctors and so the language can be technical. However, some people find that they add depth to the articles found in the other sections of this website which are written for non-medical people.

Hallucinogen Persisting Perception Disorder

Synonym: HPPD, 'Flashbacks'

This condition occurs in those who have previously taken hallucinogenic recreational drugs, usually on a number of occasions.1
After the drug-related mind alteration has finished they may experience visual symptoms akin to the original hallucinogenic experience. The term flashback, although used synonymously by some, is in fact a discrete but ill-defined phenomenon. The term has been used heterogeneously over the years in the literature, and hence is felt to be useless as a defining term by some authors.2 It describes a short-term transient, episodic, non-disturbing, reversible and benign re-experiencing of visual symptoms originally encountered during a drug experience.

HPPD, by contrast, is a persistent, pervasive, long-term, dysphoric and distressing condition. It may be irreversible or persist for months or years. Its effects are clearly non-benign and accompanied by a sense of dysphoria.3 The symptoms must cause distress or social, occupational or other impairment and not be due to an underlying medical condition. Equally, the symptoms should not be due to another mental disorder such as dementia, delirium or schizophrenia, and not be associated with waking or falling to sleep when hypnopompic or hypnagogic hallucinations are a more likely cause.

Epidemiology

Exceedingly uncommon on a population basis and probably still extremely rare in the population that has taken hallucinogenic drugs. No reliable prevalence data is available. However, a worrying increase has been reported in the use of hallucinogens in UK dance drug users.4

Risk factors

Previous use of hallucinogenic or similar drug. There are case reports of the symptoms occurring after taking a variety of psychoactive drugs, as well as the classical hallucinogens.5,6 It appears unusual for the condition to follow first exposure to a drug. Other purported risk factors are unproven due to the small number of cases studied and lack of comparison to suitable control populations.2

Presentation7

Symptoms

Geometric pattern visual hallucinations Seeing movements in peripheral vision when nothing there
Moving objects leaving trails or after-images Positive after-images
Colour flashes in low lighting conditions Hyperintense colours
Haloes around objects Macropsia and micropsia

Differential diagnosis8
  • Persisting intoxication with hallucinogen (do not diagnose until appreciable period has passed and acute effects definitely curtailed)
  • Functional brain disorder, e.g. schizophrenia
  • Organic brain disorder, e.g. brain tumour, delirium, dementia, visual hallucination due to epileptic activity
  • Visual hallucinations due to another drug and/or associated medical condition, e.g. Parkinson's disease and L-DOPA
  • Factitious illness
  • Acute withdrawal from alcohol or drugs (take full substance use history)
  • Ocular disease causing perceptual disturbance
  • Hypnogogic or hypnapompic hallucinations
Investigations

No useful confirmatory tests. Screening blood tests, cerebral imaging and EEG may be used to exclude other causes of the symptoms.

Management

Case reports of successful management with neuroleptics, anticonvulsants, benzodiazepines, SSRIs and clonidine.9,10,11 No randomised controlled trial data available to support their use.2 Referral to specialist centre experienced in dealing with the problem is advisable.

Prognosis7

Symptoms should settle over a period of months, and do seem to respond to pharmacotherapy in the majority of cases. However, some patients may experience distressing symptoms that last for years or are irreversible.

Prevention7

Avoidance of hallucinogenic and other recreational drugs associated with the condition. Failing that, avoidance of excessive or frequently repeated use of these drugs.


Document references
  1. Diagnostic criteria for 292.89; Hallucinogen Persisting Perception Disorder (Flashbacks)Behavenet.com 2008
  2. Halpern JH, Pope HG Jr; Hallucinogen persisting perception disorder: what do we know after 50 years? Drug Alcohol Depend. 2003 Mar 1;69(2):109-19. [abstract]
  3. Lerner AG, Gelkopf M, Skladman I, et al; Flashback and Hallucinogen Persisting Perception Disorder: clinical aspects and pharmacological treatment approach. Isr J Psychiatry Relat Sci. 2002;39(2):92-9. [abstract]
  4. McCambridge J, Winstock A, Hunt N, et al; 5-Year trends in use of hallucinogens and other adjunct drugs among UK dance drug users. Eur Addict Res. 2007;13(1):57-64. [abstract]
  5. Espiard ML, Lecardeur L, Abadie P, et al; Hallucinogen persisting perception disorder after psilocybin consumption: a case study. Eur Psychiatry. 2005 Aug;20(5-6):458-60. [abstract]
  6. Gaillard MC, Borruat FX; Persisting visual hallucinations and illusions in previously drug-addicted patients. Klin Monatsbl Augenheilkd. 2003 Mar;220(3):176-8. [abstract]
  7. HPPD FAQ; erowid.org 2001
  8. Disorder Information Sheet; psychnet-uk.com 2008
  9. Lerner AG, Gelkopf M, Skladman I, et al; Clonazepam treatment of lysergic acid diethylamide-induced hallucinogen persisting perception disorder with anxiety features. Int Clin Psychopharmacol. 2003 Mar;18(2):101-5. [abstract]
  10. Lerner AG, Shufman E, Kodesh A, et al; LSD-induced Hallucinogen Persisting Perception Disorder with depressive features treated with reboxetine: case report. Isr J Psychiatry Relat Sci. 2002;39(2):100-3. [abstract]
  11. Lerner AG, Gelkopf M, Oyffe I, et al; LSD-induced hallucinogen persisting perception disorder treatment with clonidine: an open pilot study. Int Clin Psychopharmacol. 2000 Jan;15(1):35-7. [abstract]
Acknowledgements EMIS is grateful to Dr Laurence Knott for writing this article. The final copy has passed scrutiny by the independent Mentor GP reviewing team. ©EMIS 2008.
DocID: 2227
Document Version: 20
DocRef: bgp2206
Last Updated: 16 Mar 2008
Review Date: 16 Mar 2010








Disclaimer: Patient UK has no control over the content of any external links above. Inclusion does not imply endorsement by Patient UK.

Want to advertise on this site? Find out how >>








Disclaimer: Patient UK has no control over the content of any external links above. Inclusion does not imply endorsement by Patient UK.

Want to advertise on this site? Find out how >>


PS - Health and Poverty

Perhaps the biggest cause of ill health in the world is poverty. Help to Make Poverty History. For example, why not lend some of your money to disadvantaged communities to enable them to trade their way out of poverty through schemes such as Shared Interest.

See also MAKEPOVERTYHISTORY North East for details and links to campaigns against poverty.

^ Top of Page